NIS [non-interventional study] for patients using Symbicort [Budesonide/formoterol] turbuhaler for maintenance and reliever therapy in a single inhaler.
Phase of Trial: Phase III
Latest Information Update: 06 Oct 2008
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 06 Oct 2008 Last checked against ClinicalTrials.gov record.
- 24 Sep 2008 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.
- 24 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.